The United Laboratories International Holdings Limited provided earnings guidance for the six months ended 30 June 2019. The net profit of the Group for the six months ended 30 June 2019 is expected to record a net profit of approximately RMB 280,000,000, while the net profit for the six months ended 30 June 2018 is approximately RMB 91,000,000. During the period, sales income of bulk medicine and finished products have increased resulting increase in overall gross profit. The fair value change of embedded derivative components of convertible bonds records a gain of approximately RMB 52,000,000 while there is a loss of approximately RMB 281,000,000 in same period last year.